Premature infants who received hydrocortisone treatment for the prevention of bronchopulmonary dysplasia did not show any differences in rates of delays in cognitive, motor, or academic performance ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review covers Beyfortus (from Sanofi and AstraZeneca) ...

“I certainly hope nothing regulatory comes of this, because there’s no basis for it,” Dr Sean O’Leary, of the American Academy of Pediatrics told NBC News. HealthDay News — Federal regulators have ...

FDA Reviewing RSV Drugs for Infants, Though No Safety Issues Found THURSDAY, Dec. 11, 2025 (HealthDay News) — Federal regulators have begun a safety review of two RSV medicines used to protect infants ...

The U.S. Food and Drug Administration is reviewing two RSV drugs for infants No safety issues have been found Experts warn restricting the drugs could lead to more infant RSV hospitalizations THURSDAY ...

A comprehensive review of hepatitis B vaccination found no evidence that delaying the birth dose provides any safety or efficacy benefits and identified substantial risks associated with changing long ...

A group of vaccine advisers on Friday (December 5) removed the long-standing recommendation that all US newborns receive the hepatitis B vaccine at birth, marking a major policy shift championed by ...

Belgian authorities are investigating the theft of an infant Jesus figure from a Christmas Nativity scene in Brussels, an icon that had previously drawn widespread online scorn for its unusual design.

Rama Devi, who was visiting her parents in Kheriya Shafik. was sleeping with her daughter in the courtyard at the time of the attack Forest officials were yet to confirm if a wolf was involved in the ...

The review covers Beyfortus (from Sanofi and AstraZeneca) and Enflonsia (from Merck), both monoclonal antibodies that help shield babies from respiratory syncytial virus, or RSV. The move comes as ...

In a historic vote, the Centers for Disease Control and Prevention's vaccine advisers recommended narrowing the agency's hepatitis B immunization guidance for newborns. The result, if approved by the ...

THURSDAY, Dec. 11, 2025 (HealthDay News) — Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review ...